Quantification of the β-adrenoceptor ligand S-1′-[18F]fluorocarazolol in plasma of humans, rats and sheep

Journal of Chromatography B: Biomedical Applications

Volumn 678, Issue 2, 1996, Pages 253-260

  Van Waarde, Aren ^a   Visser, Ton J ^a   Posthumus, Hendrika ^a   Elsinga, Philip H ^a   Anthonio, Rutger L ^a   Van Loenen Weemaes, Anne Miek A ^a   Visser, Gerben M ^a   Beaufort Krol, Gertie C M ^a   Paans, Anne M J ^a   Vaalburg, Willem ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Fluorocarazolol

Indexed keywords

1' FLUOROCARAZOLOL; BETA ADRENERGIC RECEPTOR; CARAZOLOL; FLUORINE 18; UNCLASSIFIED DRUG; CARBAZOLE DERIVATIVE; FLUORINE; FLUOROCARAZOLOL; PLASMA PROTEIN; PROPANOLAMINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SHEEP; SOLID PHASE EXTRACTION; TECHNIQUE; ULTRAFILTRATION; AGED; ANIMAL; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PROTEIN BINDING; WISTAR RAT;

ADULT; AGED; ANIMALS; BLOOD PROTEINS; CARBAZOLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; KINETICS; MALE; MIDDLE AGED; PROPANOLAMINES; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; SHEEP; ULTRAFILTRATION;

EID: 0029658957     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-4347(95)00472-6     Document Type: Article

References (18)

1. R.B. Innis, F.M.A. Correa and S.H. Snyder, Life Sci., 24 (1979) 2255.
2. T.H. Morris and A.J. Kaumann, Naunyn Schmiedebergs Arch. Pharmacol., 308 (Suppl.) (1979) R33 (Abstract).
3. T.H. Morris, L. Birnbaumer and A.J. Kaumann, Naunyn Schmiedebergs Arch. Pharmacol., 303 (1978) 295.
4. B.I. Costin, S.R. O'Donnell and J.C. Wanstall, J. Pharm. Pharmacol., 35 (1983) 590.
5. W.C. Eckelman, R.E. Gibson, F. Vieras, W.J. Rzeszotarski, B.E. Francis and R.C. Reba, J. Nucl. Med., 21 (1980) 436.
6. A. Van Waarde, P.H. Elsinga, O.E. Brodde, G.M. Visser and W. Vaalburg, Eur. J Pharmacol., 272 (1995) 159.
7. L.B. Zheng, M.S. Berridge and P. Ernsberger, J. Med. Chem., 37 (1994) 3219.
8. G.L.Y. Chan, K.A. Hewitt, B.D. Pate, P. Schofield, M.J. Adam and T.J. Ruth, Life Sci., 50 (1992) 309.
9. C.G. Swahn, L. Farde, C. Halldin and G. Sedvall, Hum. Psychopharmacol., 7 (1992) 97.
10. D.G. McDevitt, Eur. Heart J., 8 (Suppl. M) (1987) 9.
11. U. Borchard, Clin. Physiol. Biochem., 8 (Suppl. 2) (1990) 28.
12. J. Meier, Am. Heart J., 104 (1982) 364.
13. P.H. Elsinga, M.G. Vos, A. Van Waarde, A.H. Braker, T.J. De Groot, R.L. Anthonio, A.M.A. Weemaes, O.E. Brodde, G.M. Visser and W. Vaalburg, Nucl. Med. Biol., in press.
14. P.M. Belpaire, M.G. Bogaert and M. Rosseneu, Eur. J Clin. Pharmacol., 22 (1982) 253.
15. J. Ganansia, G. Bianchetti and J.P. Thenot, J. Chromatogr., 421 (1987) 83.
16. H.J. Keukens and M.M. Aerts, J. Chromatogr., 464 (1989) 149.
17. B. Mazière, R. Cantineau, H.H. Coenen, M. Guillaume, C. Halldin, A. Luxen, C. Loc'h and S.K. Luthra, in G. Stöcklin and V.W. Pike (Editors), Radiopharmaceuticals for Positron Emission Tomography, Methodological Aspects, Kluwer Academic Publishers, Dordrecht, 1993, pp. 151-178.
18. A. Van Waarde, R.L. Anthonio, T.J. Visser, P.H. Elsinga, H. Posthumus, A.M.A. Weemaes, P.K. Blanksma, G.M. Visser, A.M.J. Paans and W. Vaalburg, J. Chromatogr. B, 663 (1995) 361.